These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9279525)

  • 1. Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours.
    Jaïs P; Terris B; Ruszniewski P; LeRomancer M; Reyl-Desmars F; Vissuzaine C; Cadiot G; Mignon M; Lewin MJ
    Eur J Clin Invest; 1997 Aug; 27(8):639-44. PubMed ID: 9279525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.
    de Sá SV; Corrêa-Giannella ML; Machado MC; de Souza JJ; Pereira MA; Patzina RA; Siqueira SA; Machado MC; Giannella-Neto D
    Endocr Relat Cancer; 2006 Mar; 13(1):69-78. PubMed ID: 16601280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
    Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
    J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.
    Papotti M; Bongiovanni M; Volante M; Allìa E; Landolfi S; Helboe L; Schindler M; Cole SL; Bussolati G
    Virchows Arch; 2002 May; 440(5):461-75. PubMed ID: 12021920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.
    John M; Meyerhof W; Richter D; Waser B; Schaer JC; Scherübl H; Boese-Landgraf J; Neuhaus P; Ziske C; Mölling K; Riecken EO; Reubi JC; Wiedenmann B
    Gut; 1996 Jan; 38(1):33-9. PubMed ID: 8566856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.
    Corbetta S; Ballaré E; Mantovani G; Lania A; Losa M; Di Blasio AM; Spada A
    Eur J Clin Invest; 2001 Mar; 31(3):208-14. PubMed ID: 11264647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor subtype expression in human thyroid tumours.
    Klagge A; Krause K; Schierle K; Steinert F; Dralle H; Fuhrer D
    Horm Metab Res; 2010 Apr; 42(4):237-40. PubMed ID: 20094970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide receptors in gut endocrine tumours.
    de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
    Baillieres Clin Gastroenterol; 1996 Dec; 10(4):571-87. PubMed ID: 9113313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients.
    Janson ET; Gobl A; Kälkner KM; Oberg K
    Cancer Res; 1996 Jun; 56(11):2561-5. PubMed ID: 8653698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.
    Taboada GF; Luque RM; Bastos W; Guimarães RF; Marcondes JB; Chimelli LM; Fontes R; Mata PJ; Filho PN; Carvalho DP; Kineman RD; Gadelha MR
    Eur J Endocrinol; 2007 Jan; 156(1):65-74. PubMed ID: 17218727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies.
    O'Toole D; Saveanu A; Couvelard A; Gunz G; Enjalbert A; Jaquet P; Ruszniewski P; Barlier A
    Eur J Endocrinol; 2006 Dec; 155(6):849-57. PubMed ID: 17132755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
    Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
    Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptors and disease: role of receptor subtypes.
    Hofland LJ; Lamberts SW
    Baillieres Clin Endocrinol Metab; 1996 Jan; 10(1):163-76. PubMed ID: 8734455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
    de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
    Endocr Relat Cancer; 2003 Dec; 10(4):451-8. PubMed ID: 14713257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
    Muscarella LA; D'Alessandro V; la Torre A; Copetti M; De Cata A; Parrella P; Sperandeo M; Pellegrini F; Frusciante V; Maiello E; Merla G; Fazio VM; Vendemiale G
    Cell Oncol (Dordr); 2011 Oct; 34(5):435-41. PubMed ID: 21503779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
    Modlin IM; Cornelius E; Lawton GP
    Arch Surg; 1995 Apr; 130(4):367-73; discussion 373-4. PubMed ID: 7710334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
    Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
    J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
    Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
    Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction.
    Murabe H; Shimatsu A; Ihara C; Mizuta H; Nakamura Y; Nagata I; Kikuchi H; Nakao K
    J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.